Announcement on Voluntary Disclosure of Approval by the Therapeutic Goods Administration of Australia for the Marketing of Orelabrutinib

About this update from Innocare Pharma Ltd. Class A

Announcement on Voluntary Disclosure of Approval by the Therapeutic Goods Administration of Australia for the Marketing of Orelabrutinib The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Innocare Pharma Ltd. Class A